Vertex Pharmaceuticals Incorporated VRTX reported adjusted earnings of $3.98 per share for the fourth quarter of 2024, ...

Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Acadian Asset Management Incorporated Earnings Conference Call and Webcast for the Fourth Quarter 2024.

Of the 118 biologics losing exclusivity over the next decade, only 10% have biosimilars in development, meaning a vast ...

Good morning. Welcome to USA Compression Partners Fourth Quarter 2024 Earnings Conference Call. During today’s call, all participants will be in listen-only mode. At the conclusion of management's ...

Analysts warn the U.S. office sector is teetering as more than $1 trillion in commercial real estate loans come due over the ...

OGI earnings call for the period ending December 31, 2024. Organigram ( OGI -13.84%) Q1 2025 Earnings Call Feb 11, 2025, 8:00 ...

ARLINGTON, Va., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (Nasdaq: FLNC) ("Fluence” or the "Company”), a global market leader delivering intelligent energy storage, operational services, ...

One of the most significant news items involving Vertex isn't reflected in the company's numbers just yet. Vertex's non-opioid pain relief drug, Journavx, received FDA approval on Jan. 30. The drug is ...

Elliott Investment Management confirms a more than $2.5B stake in Phillips 66 and will seek to streamline the company, most ...